Skip to main content
. Author manuscript; available in PMC: 2024 Aug 2.
Published in final edited form as: Spine (Phila Pa 1976). 2021 Feb 1;46(3):E203–E212. doi: 10.1097/BRS.0000000000003751

Figure 2.

Figure 2.

(A) Preoperative hydromorphone use and reoperation rates after posterior lumbar interbody fusion. (B) Preoperative oxycodone use and reoperation rates after posterior lumbar interbody fusion. (C) Preoperative hydrocodone use and reoperation rates after posterior lumbar interbody fusion. (D) Preoperative tramadol use and reoperation rates after posterior lumbar interbody fusion. (E) Preoperative ER oxycodone use and reoperation rates after posterior lumbar interbody fusion.